Saturday 17 October 2026
Export GRFS’s income statement to Excel — free account
Grifols, S.A.
GRFS Healthcare Drug Manufacturers General
Grifols, S.A.’s revenue for fiscal 2025 (year ended December 2025) was $8.5 billion, up 9.07% from fiscal 2024. In the quarter to June 2026, revenue grew 5.76%, EPS grew 466.9%, free cash flow grew 300.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
7.64
0.10
+1.33%
Follow GRFS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
4.52% | 6.28% | 5.33% | 0.00% | |
| 1.70% | 2.04% | 2.09% | 0.00% | ||
ROIC |
4.70% | 4.74% | 4.51% | 0.00% | |
Return on Tangible Assets |
5.44% | 6.51% | 6.48% | 0.00% | |
Average Days of Receivables |
52.20 | 36.48 | 42.76 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.95 | 0.00 | 0.00 | |
Free Cash Flow |
488.50 | 645.83 | 602.42 | 739.71 | |
Capital Expenditures |
(563.15) | (538.74) | (568.18) | (506.66) | |
| Other line items | |||||
Cash ROIC |
2.31% | 3.15% | 2.82% | 3.52% | |
Accounts Receivable Turnover |
7.89 | 8.86 | 8.36 | 0.00 | |
Accounts Payable Turnover |
0.00 | 6.10 | 0.00 | 0.00 | |
Inventory Turnover |
1.27 | 1.40 | 1.39 | 0.00 | |
Average Days of Payables |
0.00 | 65.80 | 0.00 | 0.00 | |
Days of Inventory on Hand |
288.76 | 257.89 | 273.94 | 0.00 | |
Tax Rate |
(0.27) | (0.19) | (0.19) | — | |
Research and Development Expense of Revenue |
5.14% | 5.66% | 5.64% | — | |
Selling, General and Administrative Expense of Revenue |
16.68% | 15.72% | 15.37% | — | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | — | |
Interest Coverage |
1.95 | 1.99 | 2.00 | — | |
Operating CF/Net income |
2.62 | 2.60 | 2.45 | 0.00 | |
Depreciation/Fixed assets |
0.14 | 0.14 | 0.14 | 0.14 | |
Capex/Depreciation |
(1.13) | (1.06) | (1.11) | (1.00) | |
Revenue per Share |
0.00 | 12.51 | 0.00 | — | |
Operating CF per Share |
0.00 | 1.74 | 0.00 | 0.00 | |
Capex per Share |
0.00 | (0.79) | 0.00 | 0.00 | |
Capex to Sales |
0.07 | 0.06 | 0.07 | 0.00 |
Columns are period end dates